Instadose Pharma INSD Stock
0.0011 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
OTC Markets EXMKT
Market Cap
585.13K USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
300 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.01 USD
Instadose Pharma Price Chart
Instadose Pharma INSD Financial and Trading Overview
| Instadose Pharma stock price | 0.0011 USD |
| Previous Close | 0.0011 USD |
| Open | 0.0011 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0011 - 0.0011 USD |
| 52 Week Range | 0.0003 - 2.03 USD |
| Volume | 1 USD |
| Avg. Volume | 0 USD |
| Market Cap | 585.13K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INSD Valuation Measures
| Enterprise Value | 817.32K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.01641791 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Instadose Pharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -99.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.03 USD |
| 52 Week Low | 0.0003 USD |
| 50-Day Moving Average | 0.0011 USD |
| 200-Day Moving Average | 0.15 USD |
INSD Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 531.93M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 58.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | February 28, 2022 |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.33K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 237.52K USD |
| Total Debt/Equity (mrq) | 0.67 USD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.067 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Instadose Pharma
| Country | United States |
| State | ON |
| City | Burlington |
| Address | 5500 North Service Road |
| ZIP | L7L 6W6 |
| Phone | 905 218 3593 |
| Website | https://www.instadosepharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.
Q&A For Instadose Pharma Stock
What is a current INSD stock price?
Instadose Pharma INSD stock price today per share is 0.0011 USD.
How to purchase Instadose Pharma stock?
You can buy INSD shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Instadose Pharma?
The stock symbol or ticker of Instadose Pharma is INSD.
Which industry does the Instadose Pharma company belong to?
The Instadose Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Instadose Pharma have in circulation?
The max supply of Instadose Pharma shares is 531.93M.
What is Instadose Pharma Price to Earnings Ratio (PE Ratio)?
Instadose Pharma PE Ratio is now.
What was Instadose Pharma earnings per share over the trailing 12 months (TTM)?
Instadose Pharma EPS is -0.01 USD over the trailing 12 months.
Which sector does the Instadose Pharma company belong to?
The Instadose Pharma sector is Healthcare.